v3.26.1
Net Loss per Share - Schedule of Potentially Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details) - shares
3 Months Ended 6 Months Ended
Jul. 05, 2026
Jun. 29, 2025
Jul. 05, 2026
Jun. 29, 2025
Stock options outstanding        
Subsidiary Sale Of Stock [Line Items]        
Anti-dilutive securities (in shares) 1,132,201 1,618,980 1,132,201 1,618,980
Restricted stock units and performance restricted stock units outstanding        
Subsidiary Sale Of Stock [Line Items]        
Anti-dilutive securities (in shares) 15,385,038 14,954,849 15,385,038 14,954,849
Assumed conversion of Convertible Senior Notes        
Subsidiary Sale Of Stock [Line Items]        
Anti-dilutive securities (in shares) 43,171,560 11,053,800 43,171,560 11,053,800
Private Placement Warrants outstanding        
Subsidiary Sale Of Stock [Line Items]        
Anti-dilutive securities (in shares) 5,500,000 5,500,000 5,500,000 5,500,000
Employee stock purchase plan estimated shares        
Subsidiary Sale Of Stock [Line Items]        
Anti-dilutive securities (in shares) 166,059 296,202 166,059 296,202